HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nitroimidazole action in Entamoeba histolytica: a central role for thioredoxin reductase.

Abstract
Metronidazole, a 5-nitroimidazole drug, has been the gold standard for several decades in the treatment of infections with microaerophilic protist parasites, including Entamoeba histolytica. For activation, the drug must be chemically reduced, but little is known about the targets of the active metabolites. Applying two-dimensional gel electrophoresis and mass spectrometry, we searched for protein targets in E. histolytica. Of all proteins visualized, only five were found to form adducts with metronidazole metabolites: thioredoxin, thioredoxin reductase, superoxide dismutase, purine nucleoside phosphorylase, and a previously unknown protein. Recombinant thioredoxin reductase carrying the modification displayed reduced enzymatic activity. In treated cells, essential non-protein thiols such as free cysteine were also affected by covalent adduct formation, their levels being drastically reduced. Accordingly, addition of cysteine allowed E. histolytica to survive in the presence of otherwise lethal metronidazole concentrations and reduced protein adduct formation. Finally, we discovered that thioredoxin reductase reduces metronidazole and other nitro compounds, suggesting a new model of metronidazole activation in E. histolytica with a central role for thioredoxin reductase. By reducing metronidazole, the enzyme renders itself and associated thiol-containing proteins vulnerable to adduct formation. Because thioredoxin reductase is a ubiquitous enzyme, similar processes could occur in other eukaryotic or prokaryotic organisms.
AuthorsDavid Leitsch, Daniel Kolarich, Iain B H Wilson, Friedrich Altmann, Michael Duchêne
JournalPLoS biology (PLoS Biol) Vol. 5 Issue 8 Pg. e211 (Aug 2007) ISSN: 1545-7885 [Electronic] United States
PMID17676992 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Amebicides
  • Nitroimidazoles
  • Protozoan Proteins
  • Sulfhydryl Compounds
  • Metronidazole
  • Thioredoxins
  • Thioredoxin-Disulfide Reductase
  • Cysteine
  • azomycin
Topics
  • Amebicides (chemistry, metabolism, pharmacology, therapeutic use)
  • Amino Acid Sequence
  • Animals
  • Cells, Cultured
  • Cysteine (chemistry, metabolism)
  • Entamoeba histolytica (cytology, drug effects, enzymology)
  • Entamoebiasis (drug therapy)
  • Metronidazole (chemistry, metabolism, pharmacology, therapeutic use)
  • Molecular Sequence Data
  • Nitroimidazoles (chemistry, metabolism)
  • Oxidation-Reduction
  • Protozoan Proteins (chemistry, genetics, metabolism)
  • Sulfhydryl Compounds (chemistry)
  • Thioredoxin-Disulfide Reductase (chemistry, genetics, metabolism)
  • Thioredoxins (chemistry, genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: